A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis

NCT00509847 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped conduct (recruitment) not feasible within timeframe

Conditions

Staphylococcal Infections
Bacteremia

Interventions

DRUG: human lactoferrin peptide 1-11

Sponsor

AM-Pharma